Prosecution Insights
Last updated: October 02, 2026

Examiner: FEDORKY, MEGAN TAYLOR

Tech Center 3700 • Art Units: 3792 3796

This examiner grants 28% of resolved cases

Analysis

Megan Taylor Fedorky operates within Tech Center 3700 and Art Unit 3792, where she has managed 36 resolved cases. Her prosecution history shows an allowance rate of 27.8 percent. Practitioners should prepare for the examination process when their applications are assigned to her docket, as the majority of cases do not result in an allowance. The resolved case count of 36 provides a specific look at her recent history in this unit.

The data indicates an interview lift of 40.4 percent. This figure is high compared to the baseline allowance rate of 27.8 percent, suggesting that engaging in direct communication with the examiner may increase the probability of an allowance. Practitioners should also consider the median days to allowance of 1448 when planning their prosecution budgets. This duration of 1448 days reflects the time required to navigate the examination process under her review to reach a final grant. These metrics together provide a roadmap for those navigating Art Unit 3792.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

27.8%
Allow Rate
-42.2% vs TC avg
89
Total Applications
+40.4%
Interview Lift
1448
Avg Prosecution Days
Based on 36 resolved cases, 2023–2026

Rejection Statute Breakdown

17.4%
§101 Eligibility
19.3%
§102 Novelty
39.6%
§103 Obviousness
22.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18819328 IMPLANTABLE MEDICAL SYSTEMS FOR CANCER TREATMENT WITH ACTIVATION ENERGY BASED THERAPY MODULATION Non-Final OA Boston Scientific Scimed, Inc.
17974844 PERCUTANEOUS CIRCULATORY SUPPORT DEVICE FACILITATING REDUCED HEMOLYSIS Non-Final OA Boston Scientific Scimed, Inc.
17051033 SENSING SYSTEMS AND METHODS FOR IDENTIFYING EMOTIONAL STRESS EVENTS Final Rejection Abbott Diabetes Care Inc.
17630969 CALIBRATING A SENSOR Non-Final OA KONINKLIJKE PHILIPS N.V.
17357921 Illness Detection Based on Modifiable Behavior Predictors Non-Final OA Oura Health Oy
17933395 NEUROSTIMULATOR TRIALING PATIENT ALERT SYSTEM Non-Final OA Medtronic, Inc.
17348002 VISUALIZATION OF ELECTRICAL SIGNALS PROPAGATING OVER THE SURFACE OF PATIENT ORGAN Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
17192496 MODULAR CARDIAC PATIENT TREATMENT AND MONITORING Final Rejection WEST AFFUM HOLDINGS DAC
17853281 HEARING PROSTHESIS SYSTEM Final Rejection Advanced Bionics AG
17287495 Current Source for Neurostimulation Final Rejection Saluda Medical Pty Ltd
17287494 Method and Device for Controlled Neural Stimulation Non-Final OA Saluda Medical Pty Ltd
17236266 SYSTEMS, METHODS, AND DEVICES FOR DETERMINING MILD TRAUMATIC BRAIN INJURIES Final Rejection Research Triangle Institute
17421173 SYSTEMS AND METHODS FOR PHYSIOLOGY MONITORING KNEE BRACE Non-Final OA MGI Holdco Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month